# Sertraline and the Risk of Serious Adverse Events

> **NCT07387120** · — · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 6893 (actual)

## Conditions studied

- Chronic Kidney Disease (CKD)
- Elderly
- Outpatient

## Interventions

- **DRUG:** Sertraline 50 mg
- **DRUG:** Sertraline 25 mg

## Key facts

- **NCT ID:** NCT07387120
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2025-01
- **Final completion:** 2026-01
- **Target enrollment:** 6893 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07387120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07387120, "Sertraline and the Risk of Serious Adverse Events". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07387120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*